Detalles de la búsqueda
1.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199127
2.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560813
3.
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry.
Haematologica
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634126
4.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150388
5.
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
Cancer
; 127(12): 2003-2014, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626197
6.
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica
; 106(12): 3079-3089, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179471
7.
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
Eur J Haematol
; 105(2): 138-147, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243655
8.
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
Cancer
; 125(16): 2810-2817, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012967
9.
Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
Mycoses
; 62(5): 418-427, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30633829
10.
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.
Biol Blood Marrow Transplant
; 24(8): 1754-1758, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29649620
11.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Br J Haematol
; 201(6): 1239-1244, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057357
12.
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 97(5): 923, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473097
13.
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 97(5): 763-772, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29392425
14.
A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.
Br J Haematol
; 174(5): 700-10, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118319
15.
Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae.
J Antimicrob Chemother
; 71(11): 3242-3249, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27494911
16.
Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia.
Haematologica
; 98(12): 1877-85, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23812937
17.
Identifying prognostic gene panels in acute myeloid leukemia.
Expert Rev Hematol
; 16(4): 277-287, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951195
18.
Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?
Cancers (Basel)
; 15(5)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900222
19.
Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice.
J Pers Med
; 13(12)2023 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38138894
20.
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Cancers (Basel)
; 15(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672386